Progyny, Inc. operates primarily in the United States, serving hundreds of large enterprise clients and covering millions of lives. The company's core offerings include its fertility benefits solution, which provides members with personalized concierge-style support and access to a premier network of fertility clinics. Additionally, the company operates Progyny Rx, an integrated pharmacy benefits solution that manages the dispensing and delivery of fertility medications. In recent years, Progyny has expanded its platform to include broader women's health services, such as menopause support, pregnancy and postpartum care, and reimbursement programs for surrogacy and adoption. By replacing traditional dollar-maximum fertility coverage with its treatment-based "Smart Cycle" approach, Progyny aims to improve clinical outcomes, reduce multiple birth rates, and lower overall healthcare costs for employers. The company went public in 2019 and has grown to become a leading specialized benefits manager in the family-building space.
